Salidroside alleviates cognitive impairment by inhibiting ferroptosis via activation of the Nrf2/GPX4 axis in SAMP8 mice

被引:57
|
作者
Yang, Sixia [1 ,2 ]
Wang, Linshuang [3 ]
Zeng, Yi [2 ]
Wang, Yong [1 ]
Pei, Tingting [2 ]
Xie, Zeping [2 ]
Xiong, Qiaowu [2 ]
Wei, Hui [2 ]
Li, Wenxu [2 ]
Li, Jiaqi [2 ]
Su, Qian [2 ]
Wei, Dongfeng [3 ]
Cheng, Weidong [1 ,2 ]
机构
[1] Southern Med Univ, Zhu Jiang Hosp, Dept Pharm, Guangzhou 510260, Peoples R China
[2] Southern Med Univ, Sch Tradit Chinese Med, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China
[3] China Acad Chinese Med Sci, Inst Basic Res Clin Med, 16 Nanxiao St, Beijing 100700, Peoples R China
关键词
Salidroside; Alzheimer's disease; Ferroptosis; CD8+T cells; Nrf2; T-CELLS; MOUSE MODEL; ALZHEIMERS; PATHOLOGY; BEHAVIOR; BRAINS; MAZE; TAU;
D O I
10.1016/j.phymed.2023.154762
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Alzheimer's disease (AD) is a neurogenerative disease and remains no effective method for stopping its progress. Ferroptosis and adaptive immunity have been proven to contribute to AD pathogenesis. Salidroside exhibits neuroprotective and immunomodulatory effects. However, the underlying mechanisms linking salidroside, ferroptosis, and adaptive immunity in AD remain uncertain. Purpose: The objective of this study is to explore the neuroprotective effects and the potential molecular mechanisms of salidroside against neuronal ferroptosis and CD8+ T cell infiltration in senescence-accelerated mouse prone 8 (SAMP8) mice. Study design and methods: SAMP8 mice were employed as an AD model and were treated with salidroside for 12 weeks. Behavioral tests, immunohistochemistry, HE and Nissl staining, immunofluorescence, transmission electron microscopy, quantitative proteomics, bioinformatic analysis, flow cytometry, iron staining, western blotting, and molecular docking were performed. Results: Treatment with salidroside dose-dependently attenuated cognitive impairment, reduced the accumulation of A beta plaques and restored neuronal damage. Salidroside also suppressed the infiltration of CD8+T cells, oxidative stress, and inflammatory cytokines, and improved mitochondrial metabolism, iron metabolism, lipid metabolism, and redox in the SAMP8 mice brain. The administration of salidroside decreased iron deposition, reduced TFR1, and ACSL4 protein expression, upregulated SLC7A11, and GPX4 protein expression, and promoted the Nrf2/GPX4 axis activation. Conclusion: In conclusion, neuronal ferroptosis and CD8+T cells are involved in the process of cognitive impairment in SAMP8 mice. Salidroside alleviates cognitive impairment and inhibits neuronal ferroptosis. The underlying mechanisms may involve the Nrf2/GPX4 axis activation and reduction in CD8+T cells infiltration. This study provides some evidence for the roles of salidroside in adaptive immunity and neuronal ferroptosis in SAMP8 mice.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Vitamin D Improves Cognitive Impairment and Alleviates Ferroptosis via the Nrf2 Signaling Pathway in Aging Mice
    Li, Jiaxin
    Cao, Yang
    Xu, Jie
    Li, Jing
    Lv, Chunmei
    Gao, Qiang
    Zhang, Chi
    Jin, Chongfei
    Wang, Ran
    Jiao, Runsheng
    Zhu, Hui
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (20)
  • [42] Sulforaphane alleviates high fat diet-induced insulin resistance via AMPK/Nrf2/GPx4 axis
    Zhang, Ya
    Wu, Qifang
    Liu, Jian
    Zhang, Zhongshan
    Ma, Xiaojing
    Zhang, Yaoyue
    Zhu, Jiawen
    Thring, Ronald W.
    Wu, Mingjiang
    Gao, Yitian
    Tong, Haibin
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 152
  • [43] Picein alleviates oxidative stress and promotes bone regeneration in osteoporotic bone defect by inhibiting ferroptosis via Nrf2/HO-1/GPX4 pathway
    Huang, Lei
    Wang, Jiayi
    Yu, Jieqin
    Bian, Mengxuan
    Xiang, Xingdong
    Han, Guanjie
    Chen, Weisin
    Wang, Ning
    Ge, Jun
    Lu, Shunyi
    Zhang, Jian
    ENVIRONMENTAL TOXICOLOGY, 2024, : 4066 - 4085
  • [44] Bioactive compound schaftoside from Clinacanthus nutans attenuates acute liver injury by inhibiting ferroptosis through activation the Nrf2/ GPX4 pathway
    Yu, Yi
    Liang, Jingwei
    Yuan, Zhexin
    Wang, Aiping
    Liu, Xinxing
    Chen, Yu
    Zhang, Min
    Gao, Yanan
    Zhang, Haiying
    Liu, Yan
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 328
  • [45] Estrogen deficiency accelerates postmenopausal atherosclerosis by inducing endothelial cell ferroptosis through inhibiting NRF2/GPX4 pathway
    Lv, Ying
    Zhang, Shan
    Weng, Xiuzhu
    Huang, Jianxin
    Zhao, Honggang
    Dai, Xinyu
    Bai, Xiaoxuan
    Bao, Xiaoyi
    Zhao, Chen
    Zeng, Ming
    Bai, Yunshu
    Hu, Sining
    Li, Ji
    Jia, Haibo
    Yu, Bo
    FASEB JOURNAL, 2023, 37 (06)
  • [46] Vaccarin Ameliorates Renal Fibrosis by Inhibiting Ferroptosis via Nrf2/SLC7A11/GPX4 Signaling Pathway
    Cui, Mengjiao
    Xu, Qiming
    Duan, Lianxiang
    Lu, Jianrao
    Hu, Jing
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 1609 - 1626
  • [47] Quercetin attenuates the symptoms of osteoarthritis in vitro and in vivo by suppressing ferroptosis via activation of AMPK/Nrf2/Gpx4 signaling
    Dong, Shiyu
    Li, Xiaoliang
    Xu, Genrong
    Chen, Liming
    Zhao, Jiyang
    MOLECULAR MEDICINE REPORTS, 2025, 31 (03)
  • [48] BSA-stabilized selenium nanoparticles ameliorate intracerebral hemorrhage's-like pathology by inhibiting ferroptosis-mediated neurotoxicology via Nrf2/GPX4 axis activation
    Li, Xiao-Na
    Lin, Li
    Li, Xiao-Wei
    Zhu, Qian
    Xie, Zhen-Yan
    Hu, Yong-Zhen
    Long, Qing-Shan
    Wei, Xiao-Bing
    Wen, Yi-Qi
    Zhang, Li-Yang
    Zhang, Qi-Keng
    Jing, Ying-Chao
    Wei, Xin-Hua
    Li, Xue-Song
    REDOX BIOLOGY, 2024, 75
  • [49] Cordycepin alleviates osteoarthritis by inhibiting chondrocyte ferroptosis via Keap1/Nrf2 axis
    Li, Jianlei
    Lv, Zuo
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 10 (01)
  • [50] Ozone pretreatment alleviates ischemia-reperfusion injury-induced myocardial ferroptosis by activating the Nrf2/Slc7a11/Gpx4 axis
    Ding, Shengyang
    Duanmu, Xinyu
    Xu, Lingshan
    Zhu, Liang
    Wu, Zhouquan
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165